Literature DB >> 30460586

["Decoratively figured blisters" on the whole integument in initially diagnosed ulcerative colitis].

Wolfgang Konschake1, Georg Daeschlein2, Michael Jünger2, Stine Lutze2.   

Abstract

The rare case of a 61-year-old patient suffering from linear IgA dermatosis is presented. The patient was previously hospitalized with chronic inflammatory bowel disease. The correct diagnosis of the disease was based on clinical and histological findings. Serological methods, such as indirect immunofluorescence, ELISA and immunoblotting are suitable for identification of the autoantibodies. In this case the detection of IgA antibodies along the basal membrane was achieved by direct immunofluorescence. Other bullous dermatoses with similar symptoms, such as an IgG-mediated bullous pemphigoid have to be excluded. The therapy of linear IgA dermatosis is ensured by steroid-containing topical agents, alongside antiseptic measures as well as systemic dapsone p.o.

Entities:  

Keywords:  Autoantibodies; Case report; Chronic inflammatory bowel disease; Direct immunofluorescence; Linear IgA dermatosis

Mesh:

Substances:

Year:  2019        PMID: 30460586     DOI: 10.1007/s00105-018-4314-3

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  14 in total

Review 1.  Linear IgA bullous dermatosis.

Authors:  S V Guide; M P Marinkovich
Journal:  Clin Dermatol       Date:  2001 Nov-Dec       Impact factor: 3.541

2.  Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies.

Authors:  Cassian Sitaru; Cornelia Dähnrich; Christian Probst; Lars Komorowski; Inga Blöcker; Enno Schmidt; Wolfgang Schlumberger; Christian Rose; Winfried Stöcker; Detlef Zillikens
Journal:  Exp Dermatol       Date:  2007-09       Impact factor: 3.960

3.  IgA autoantibodies against the NC16a domain of BP180 but not 120-kDa LAD-1 detected in a patient with linear IgA disease.

Authors:  N Ishii; B Ohyama; Z Yamaguchi; T Hashimoto
Journal:  Br J Dermatol       Date:  2008-03-20       Impact factor: 9.302

4.  [Pediatric linear IgA/IgG dermatosis].

Authors:  Orsolya N Horváth; Tanja von Braunmühl; Miklós Sárdy
Journal:  Hautarzt       Date:  2018-10       Impact factor: 0.751

5.  Circulating autoantibodies to tissue transglutaminase differentiate patients with dermatitis herpetiformis from those with linear IgA disease.

Authors:  C Rose; W Dieterich; E B Bröcker; D Schuppan; D Zillikens
Journal:  J Am Acad Dermatol       Date:  1999-12       Impact factor: 11.527

6.  Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques.

Authors:  W S Selby; G Janossy; M Bofill; D P Jewell
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

Review 7.  IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature.

Authors:  Robert M Vodegel; Marcelus C J M de Jong; Hendri H Pas; Marcel F Jonkman
Journal:  J Am Acad Dermatol       Date:  2002-12       Impact factor: 11.527

8.  [Diagnostic use of autoantibodies].

Authors:  C Günther; M Hertl; M Meurer
Journal:  Hautarzt       Date:  2007-12       Impact factor: 0.751

9.  Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy.

Authors:  Nina van Beek; Kristin Rentzsch; Christian Probst; Lars Komorowski; Michael Kasperkiewicz; Kai Fechner; Inga M Bloecker; Detlef Zillikens; Winfried Stöcker; Enno Schmidt
Journal:  Orphanet J Rare Dis       Date:  2012-08-09       Impact factor: 4.123

10.  Development of an ELISA for sensitive and specific detection of IgA autoantibodies against BP180 in pemphigoid diseases.

Authors:  Kinga Csorba; Sabine Schmidt; Florina Florea; Norito Ishii; Takashi Hashimoto; Michael Hertl; Sarolta Kárpáti; Leena Bruckner-Tuderman; Wataru Nishie; Cassian Sitaru
Journal:  Orphanet J Rare Dis       Date:  2011-05-28       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.